Michael  Abern, MD; Daniel George, MD; and Andrew Armstrong, MD
Leadership of the Duke Cancer Institute center for Prostate and Urologic Cancers (from left to right): Michael Abern, MD; Daniel George, MD; and Andrew Armstrong, MD

Center for Prostate and Urologic Cancers

The DCI Center for Prostate and Urologic Cancers is a multidisciplinary team of physicians and researchers who are leaders in screening, diagnosing, and treating prostate and urologic cancers. The center is a major referral center and specializes in difficult-to-treat prostate cancers. We are also nationally recognized leaders in clinical, translational, and population research in the areas of health disparities, immunotherapy, population sciences, and RNA targets and therapeutics. Our overall goal is to improve survival rates and quality of life in patients with testicular cancer, bladder cancer, kidney cancer, and prostate cancer.

gift purple logo

Donate to Support the Center for Prostate and Urologic Cancers

Make a Gift
duke health logo

Visit DukeHealth.org for more information about prostate cancer treatment.

This page was reviewed on 11/15/2023